Morning Briefing
Summaries of health policy coverage from major news organizations
Clinton Foundation Reaches Deal With Matrix, Pfizer To Cut Prices For Second-Line ARVs, TB Drug
Former President Bill Clinton on Thursday announced deals with drugmakers Matrix Laboratories and Pfizer to lower the cost of medications to treat patients with drug-resistant forms of HIV/AIDS in the developing world, Reuters reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
